The opioids crisis that has taken hundreds of thousands of American lives has received less attention in the pandemic, but drug overdoses and deaths have grown during the last year. Now, one of the world's most powerful corporate consulting firms…
By Stephanie Sy
In our news wrap Thursday, a second COVID-19 vaccine moves closer to emergency authorization, President-elect Biden rounds out his environmental team, Vladimir Putin denies ordering opposition leader's poisoning, more than 340 boys kidnapped in Nigeria are freed, the family that…
The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York's attorney general contends in court papers filed Friday.
By Adam Geller, Associated Press
The video is the latest eyebrow-raising piece of evidence in the trial, which has put a spotlight on the federal government's efforts to go after those it says are responsible for fueling the deadly drug crisis.
By Alanna Durkin Richer, Associated Press
The nation’s opioid crisis was declared a public health emergency in 2017 and received new funding this past October. But rampant addiction led to some 40,000 overdose deaths in the U.S. last year, and 2019 could see the culmination of…
By Megan Thielking, STAT
A neurobiologist at Mount Sinai School of Medicine in New York thinks cannabidiol -- one of the two main compounds plucked from the marijuana plant -- might hold the potential to curb cravings for heroin and other opioids.
By Elizabeth Flock
In this Florida county, some believe medication is the only thing that can stop the opioids deaths. Others say a life on medication isn't a life at all.
By PBS NewsHour, Nick Schifrin
What needs to be done to combat the national opioid crisis? A commission organized by President Trump released its initial recommendations on Monday, saying it was time to declare a national health emergency, among other suggestions. Special correspondent Nick Schifrin…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.